# US 7,608,286 B2 · Phyto-nutraceutical synergistic composition for hyperlipedemic condition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 7,608,286 B2
- Document ID: US7608286B2
- Status: Granted
- Kind: B2
- Application number: 11/461,172
- Filed: 2006-09-21
- Published: 2008-11-13
- Granted: 2009-10-27
- Earliest claimed: 2006-09-21
- Assignees: Jose Angel Olalde Rangel
- Inventors: Jose Angel Olalde Rangel
- Web page: https://patentgrep.com/patent/US7608286B2

## CPC

- A61K 36/21: Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
- A61K 31/44: Non condensed pyridines; Hydrogenated derivatives thereof
- A61K 31/722: Chitin, chitosan
- A61K 36/062: Ascomycota
- A61K 36/068: Cordyceps
- A61K 36/07: Basidiomycota, e.g. Cryptococcus
- A61K 36/074: Ganoderma
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/233: Bupleurum
- A61K 36/254: Acanthopanax or Eleutherococcus
- A61K 36/258: Panax (ginseng)
- A61K 36/344: Codonopsis
- A61K 36/638: Ligustrum, e.g. Chinese privet
- A61K 36/704: Polygonum, e.g. knotweed
- A61K 36/746: Morinda
- A61K 36/79: Schisandraceae (Schisandra family)
- A61K 36/8945: Dioscorea, e.g. yam, Chinese yam or water yam
- A61K 36/8962: Allium, e.g. garden onion, leek, garlic or chives
- A61K 36/9068: Zingiber, e.g. garden ginger
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A Phytoceutical composition for the prevention and treatment of hyperlipidemia—cholesterol and triglyceride disorder—is provided. A specific combination of extracts of plants and nutraceuticals is taught, as well as principles for varying the formulations based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants and nutraceuticals from each group. Such combinations have synergistic effects, with minimal side effects.

## Claims

### Claim 1

A phytoceutical composition for treating hyperlipidemia comprising: Codonopsis pilosula, 17.18 mg; Eleutherococcus senticosus, 14 mg; Panax ginseng, 14 mg; Panax quinquefolius, 54 mg; Pfaffia paniculata, 86 mg; Schizandra chinensis, 42.96 mg; Ganoderma lucidum, 103 mg; Grifola frondosa, 103 mg; Lentinus edodes, 103 mg; Morinda citrifolia, 69 mg; Allium sativum, 14 mg; Bupleurum chinense, 17.18 mg; Camellia sinensis, 17.18 mg; Chitosan, 17.18 mg; Cordyceps sinensis, 103 mg; Dioscorea villosa, 17 mg; Ligustrum lucidum, 8.59 mg; Lycium barbarum, 8.59 mg; Monascus purpureus, 42.96 mg; Niacin, 8 mg; Polygonum multiflorum, 8.59 mg; Tribulus terrestris, 23 mg; and Zingiber officinalis8.59 mg; together with pharmaceutically acceptable excipients.